Baird Medical has received new Class III certificate for its ceramic thyroid ablation needle from China’s National Medical Products Administration (NMPA).
The certificate recognises the needle’s advanced design for treating thyroid nodules, utilising rare earth ceramic materials for improved heat resistance, chemical stability, and electrical insulation.
Baird Medical’s needle is designed to distribute energy uniformly within the tissue during microwave ablation treatments. This reduces edge heating effects and increases mechanical strength by an estimated 30%.
The improvement in material strength enhances the needle’s flexibility and reliability, crucial for the precision required in delicate surgeries. The needle’s robust construction also minimises the risk of breakage.
Baird Medical founder and CEO Haimei Wu said: “The introduction of the Ceramic Thyroid Ablation Needle signifies another breakthrough innovation in the field of microwave ablation and is a testament to our ongoing commitment to innovation and research.
“We eagerly anticipate the positive impact of this technology by enhancing the patient treatment experiences and saving lives in the years to come.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe ceramic materials used in the needle optimise heating, allowing for more consistent microwave energy penetration and a 20-30% increase in heating efficiency. High-temperature sintering technology and specialised processes for connecting the needle shaft contribute to this heightened efficiency.
The NMPA’s 2023 updates to the Medical Device Classification Catalog saw Microwave Ablation Devices reclassified from Class II to Class III.
In November 2023, the US Food and Drug Administration (FDA) cleared Baird Medical’s microwave ablation (MWA) system and disposable needles for use in the US.
The technology helps to ablate thyroid nodules, breast tumours and other diseases where soft tissue needs to be removed.